| 000 | 01810 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515232725.0 | ||
| 264 | 0 | _c20110502 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdq354 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrederiksen, C | |
| 245 | 0 | 0 |
_aPlasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cFeb 2011 |
||
| 300 |
_a369-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aOxaloacetates |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aQvortrup, C | |
| 700 | 1 | _aChristensen, I J | |
| 700 | 1 | _aGlimelius, B | |
| 700 | 1 | _aBerglund, A | |
| 700 | 1 | _aJensen, B V | |
| 700 | 1 | _aNielsen, S E | |
| 700 | 1 | _aKeldsen, N | |
| 700 | 1 | _aNielsen, H J | |
| 700 | 1 | _aBrünner, N | |
| 700 | 1 | _aPfeiffer, P | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 22 _gno. 2 _gp. 369-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdq354 _zAvailable from publisher's website |
| 999 |
_c19985058 _d19985058 |
||